CSGALNACT2 抗体 (AA 200-229)
Quick Overview for CSGALNACT2 抗体 (AA 200-229) (ABIN652723)
抗原
See all CSGALNACT2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 200-229
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This CSGALNACT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-229 amino acids from the Central region of human CSGALNACT2.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
- WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
有效期
- 6 months
-
-
-
: "Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis." in: Biochemical and biophysical research communications, Vol. 406, Issue 1, pp. 36-41, (2011) (PubMed).
-
: "Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis." in: Biochemical and biophysical research communications, Vol. 406, Issue 1, pp. 36-41, (2011) (PubMed).
-
- CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))
-
别名
- CSGALNACT2
-
背景
- Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). It is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.
-
分子量
- 62572
-
基因ID
- 55454
-
NCBI登录号
- NP_061060
-
UniProt
- Q8N6G5
-
途径
- Glycosaminoglycan Metabolic Process
抗原
-